2024-513799-16-00Not yet recruitingPhase 4
Acetazolamide in combination with SGLT2i in patients with volume overload and acute heart failure
Source: EU CTIS (euclinicaltrials.eu) · Last updated 15 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Improvement in natriuresis
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 17 Dec 2024
- Start date
- 22 Jan 2024
- Lead sponsor
- Ziekenhuis Oost Limburg
- Diseases
- Heart failure
- EU CT number
- 2024-513799-16-00
- EudraCT number
- 2023-000167-31
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 30
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Lab values
- Kidney function impairment with an eGFR <20ml/min/1.73m² (result within last 6 months)
Other
- Inability to collect 24h urine collections
- Systolic blood pressure below 90mmHg
Who the study is looking for
- 18 years or older
- Heart Failure
- Maintenance therapy with loop diuretics of at least 40mg of furosemide or equivalents
- Deemed volume overloaded by treating cardiologist warranting the addition of SGLT2i and IV loop diuretic therapy
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ziekenhuis Oost-Limburg | Genk | Belgium | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.